IDC FutureScape: Worldwide Life Sciences 2022 Predictions

IDC FutureScape Figure

• Figure: IDC FutureScape: Worldwide Life Sciences 2022 Top 10 Predictions

Executive Summary

IDC FutureScape Predictions

• Summary of External Drivers

• Predictions: Impact on Technology Buyers

• Prediction 1: By 2023, 75% of Life Sciences Manufacturers Will Invest in Intelligent Supply Chain Solutions to Enable Resilience and Prevent Future Disruptions During Health Emergencies Such as COVID-19

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 2: By 2024, AI Investments in In Silico Drug Discovery Will Double to Fuel Growth of Genomics and Precision Medicine to Bring Vital Vaccines and Medicines to Patients Faster

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 3: By 2025, 75% of Trials Will Be Patient-Centric Decentralized Clinical Trials; 90% Will Be Hybrid and at Least 10% Will Be Virtual, Driven by 30% Growth in Connected Health Technologies

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 4: By 2025, the Market for Prescription Digital Therapeutics Will More Than Triple, Led by Mental Health and Chronic Conditions, Blurring the Boundaries Between Healthcare and Life Sciences

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 5: Investment in AI for Real-World Evidence by Life Sciences Companies Will Double by 2025, Driven by Health Data Interoperability Initiatives and Platforms

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 6: By 2026, Two-Thirds of Life Sciences Companies Will Adopt the Intelligent Lab of the Future Leveraging Digital Transformation, Integrating the Internet of Lab Things

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 7: By 2026, the Increased Adoption of Medication Adherence Apps, Smart IoT–Based Solutions, and Connected Drug Delivery Systems Will Reduce Treatment Compliance Gaps in Clinical Trials by One-Third

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 8: The Use of Digital Twins in Manufacturing and Supply Chain Planning at Multinational Life Sciences Firms Will Double by 2026, with Deeper Adoption in R&D Coming Later

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 9: Triggered by COVID-19, Half of New Business Value Created in the Global Life Sciences Market by 2026 Will Be Driven by Cloud-Based Digital Ecosystems and Federated Learning, Powering R&D Co-Innovation

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

• Prediction 10: Integrated Research Organizations Will Double in Number by 2027, Fueling the Adoption of Clinical Research as a Care Option Within the Healthcare Ecosystem

• Associated Drivers

• IT Impact

• Patient Impact

• Guidance

Advice for Technology Buyers

External Drivers: Detail

• Pervasive Disruption Continues — Volatility, Opportunity, and Resilience

• Cybersecurity and Risk — The Threat Environment Just Keeps Scaling

• The Future Enterprise — Thriving in a Jungle of Agile Innovation

• Embracing Digital First — New Strategies for Complexity and Ubiquity

• Digital Ecosystem — Thriving in a Multiplatform World

• Workforce Outlook — Redefining Teams, Reinventing Models, and Rethinking Leadership

• Engagement Reimagined — From Responsive to Anticipatory

Learn More

• Related Research